Early test checks if new drug alters common diabetes pill
NCT ID NCT07368569
Summary
This early-stage study aims to understand if taking a new investigational drug, BI 764198, changes how the body absorbs and processes metformin, a common medication for type 2 diabetes. It involves 14 healthy adult participants who will take both drugs together and metformin alone in a specific order. The main goal is to measure the levels of metformin in the blood to see if BI 764198 affects them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
Conditions
Explore the condition pages connected to this study.